Filing Details

Accession Number:
0001209191-13-027414
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-17 19:56:00
Reporting Period:
2013-05-15
Filing Date:
2013-05-17
Accepted Time:
2013-05-17 19:56:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI Pharmaceutical Preparations (2834) 943254365
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226064 M Susan Kanaya C/O Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Svp, Finance, Cfo And Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-15 799 $2.00 799 No 4 M Direct
Common Stock Disposition 2013-05-15 799 $14.38 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-05-15 799 $0.00 799 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
154,712 2006-02-09 2016-02-09 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.27 to $14.58 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Not applicable.